Tenaya Therapeutics, Inc.
TNYA
$0.73
-$0.01-1.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -43.39M | -19.27M | -20.18M | -20.28M | -23.28M |
| Total Depreciation and Amortization | 1.70M | 1.76M | 1.83M | 1.86M | 2.08M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.33M | 2.86M | 3.52M | 3.73M | 4.58M |
| Change in Net Operating Assets | 12.81M | -4.58M | 893.00K | -921.00K | 1.01M |
| Cash from Operations | -3.55M | -19.23M | -13.94M | -15.60M | -15.61M |
| Capital Expenditure | -159.00K | -11.00K | -67.00K | -26.00K | -142.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 8.89M | 25.13M |
| Cash from Investing | -159.00K | -11.00K | -67.00K | 8.86M | 24.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 909.00K | -- | 58.24M | 380.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -476.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -415.00K | -- | -- | -- |
| Cash from Financing | 909.00K | -415.00K | 58.24M | 380.00K | -476.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.80M | -19.66M | 44.24M | -6.36M | 8.90M |